| 000 | 01607 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518032710.0 | ||
| 264 | 0 | _c20190821 | |
| 008 | 201908s 0 0 fre d | ||
| 022 | _a1961-9049 | ||
| 024 | 7 |
_a10.3166/bspe-2019-0054 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBouhlel, S | |
| 245 | 0 | 0 |
_a[Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia]. _h[electronic resource] |
| 260 |
_bBulletin de la Societe de pathologie exotique (1990) _c2018 |
||
| 300 |
_a269-274 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInfectious Disease Transmission, Vertical _xprevention & control |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Infectious _xblood |
| 650 | 0 | 4 |
_aPregnancy Trimester, Third _xblood |
| 650 | 0 | 4 | _aPrenatal Diagnosis |
| 650 | 0 | 4 |
_aPyrimethamine _xtherapeutic use |
| 650 | 0 | 4 |
_aSeroconversion _xphysiology |
| 650 | 0 | 4 |
_aSulfadoxine _xtherapeutic use |
| 650 | 0 | 4 |
_aToxoplasmosis _xblood |
| 650 | 0 | 4 |
_aToxoplasmosis, Congenital _xblood |
| 650 | 0 | 4 |
_aTunisia _xepidemiology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBen Abdallah, R | |
| 700 | 1 | _aAoun, K | |
| 700 | 1 | _aMaatoug, R | |
| 700 | 1 | _aSouissi, O | |
| 700 | 1 | _aBouratbine, A | |
| 773 | 0 |
_tBulletin de la Societe de pathologie exotique (1990) _gvol. 111 _gno. 5 _gp. 269-274 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3166/bspe-2019-0054 _zAvailable from publisher's website |
| 999 |
_c29555035 _d29555035 |
||